Natasha Archer, MD
Basic profileDana-Farber/Boston Children's Cancer and Blood Disorders Center
Natasha Archer is an Oncology physician affiliated with Dana-Farber/Boston Children's Cancer and Blood Disorders Center. OpenAlex indexes 93 publications with 821 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Brookline Ave
Boston, MA 022155418
Telephone
617-632-3352Provider last certified this registry record 8 Sept 2025.
Clinical trials
- Optimal Timing of Ketamine Initiation for SCD Pain
Sponsor: Boston Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20252 payments
- Novo Nordisk IncProgram year20252 payments
- Agios Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes
Boston Children'S Hospital
FY2024$167,940K08DK123386 - Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes
Boston Children'S Hospital
FY2023$167,940K08DK123386 - Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes
Boston Children'S Hospital
FY2022$167,940K08DK123386
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pilot of the International Hemoglobinopathy Research Network for a multiethnic genome-wide association study
Blood Global Hematology
2026 - Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review
International Journal of Molecular Sciences
2025 - Ethical and regulatory requirements for conducting researcher-driven large-scale multinational genetic haematological studies: the INHERENT experience
Health Research Policy and Systems
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Rani George, MD, PhD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Suzanne Shusterman, MD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Yoav Binenbaum, MD, PhD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”